Neomal S. Sandanayake

Author

University College London

Also Known As

Neomal S Sandanayake, Neomal S. Sandanayake, Neomal Sandanayake

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University College London University College London Hospitals NHS Foundation Trust University College Hospital The University of Sydney The Royal Free Hospital

About

Neomal S. Sandanayake is an author at University College London specializing in medicine, pathology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	531
2	Gastroenterology	3	3	430
3	Immunology	2	2	350
4	Engineering	1	1	46
5	Allergy	1	1	206

Neomal S. Sandanayake

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Presentation and Management of Post-treatment Relapse in Autoimmune Pancreatitis/Immunoglobulin G4-Associated Cholangitis Neomal S. Sandanayake, Nicholas I. Church, Michael H. Chapman, Clinical Gastroenterology and Hepatology Autoimmune DiseaseAllergyImmunologyGastroenterologyPost-treatment Relapse	2009	206
Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection Darragh P. O’Brien, Neomal S. Sandanayake, Claire Jenkinson, Clinical Cancer Research	2014	195
Autoimmune Pancreatitis: Clinical and Radiological Features and Objective Response to Steroid Therapy in a UK Series Nicholas I. Church, Stephen P. Pereira, Maesha Deheragoda, The American Journal of Gastroenterology	2007	164
The Use of Immunoglobulin G4 Immunostaining in Diagnosing Pancreatic and Extrapancreatic Involvement in Autoimmune Pancreatitis Maesha Deheragoda, Nicholas I. Church, Manuel Rodriguez‐Justo, Clinical Gastroenterology and Hepatology Pancreatic CancerAutoimmune DiseasePancreatic Fluid CollectionMedicineImmunodeficiencies	2007	144
Endoscopic Retrograde Cholangiography Does Not Reliably Distinguish IgG4-Associated Cholangitis From Primary Sclerosing Cholangitis or Cholangiocarcinoma Evangelos Kalaitzakis, Michael J. Levy, Terumi Kamisawa, Clinical Gastroenterology and Hepatology Biliary TractBiliary CancerDistinguish Igg4-associated CholangitisGastroenterologyPathology	2011	80
Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer Michael H. Chapman, Neomal S. Sandanayake, Fausto Andreola, Journal of Clinical and Experimental Hepatology Prognostic BiomarkersMedicineBiliary CancerPathologyBiliary Tract Cancer	2011	55
R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer Wolf‐Rudiger Matull, Dipok Kumar Dhar, Lakshmana Ayaru, Liver International	2010	51
Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma Michael H. Chapman, Robert Tidswell, James Dooley, Journal of Hepatology BioinformaticsSystems BiologyEngineeringBiliary TractMedicine	2011	46
Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer Dipok Kumar Dhar, Steven W.M. Olde Damink, James Hal Brindley, Cancer	2012	41
Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab Kazi Nahar, Robert V. Rawson, Tasnia Ahmed, Journal for ImmunoTherapy of Cancer	2020	41

Page 1